New Research on Drug-resistant TB Treatment to be Presented at Paris Conference

Media Briefing hosted by Unitaid, FIND, IAVI, and TB Alliance

Happened: Tuesday, November 14, 2023 (to be presented in French), 8:30 a.m. Paris/ 7:30 a.m. London/ 2:30 a.m. NYC/ 10:30 a.m. EAT

Location: Marriott Champs Elysees, 70 Av. des Champs-Élysées, 75008 Paris, France

This media sensitization workshop will tell the story of how TB could be ended within our lifetimes through the discovery, development, and delivery of new diagnostics, vaccines, treatments, and tools, but that this depends on accelerating progress and sustaining political will and funding for the development and delivery of new TB tools. The session will put a spotlight on recent advances and set out the priorities to make Ending TB a reality.

Press release one: High Cure Rate with Drug-Resistant TB Regimen: Results of Operational Research in Central and Southeast Asia

Happened: Wednesday, November 15, 1:30 p.m. Paris/12:30 p.m. London/7:30 a.m. NYC

More information below:

Press release two: TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating New Drug Candidate for Drug-Sensitive and Drug-Resistant TB

EMBARGO: Thursday, November 16 11:00 AM PARIS/10:00 AM LONDON/5:00 AM NYC/1:00 PM NAIROBI

Please note that conference registration is required to attend

For registration visit: https://union2023.urevent.fr/media_request

Happening: Thursday, November 16, 1:30 p.m. Paris/12:30 p.m. London/7:30 a.m. NYC  

Location: Palais des Congrès de Paris

More information below: